Eric Yuen
Executive-in-Residence at Militia Hill Ventures
About
Former Director of Clinical Research at Merck and VP of Clinical Development at Johnson & Johnson, later CMO of Ultragenyx and VP Clinical Development at BioClin Therapeutics. He earned his MD from the University of Chicago and completed a neurology residency and postdoc at UCSF.
Colleagues at Militia Hill Ventures
Bill
Investor at Militia Hill Ventures
Dr. Saporito
Investor at Militia Hill Ventures
Hope D'Oyley-Gay
Executive-in-Residence at Militia Hill Ventures
Jane H. Hollingsworth
Managing Partner at Militia Hill Ventures
Joan Lau
Partner at Militia Hill Ventures
Michael Saporito
Executive-in-Residence at Militia Hill Ventures
Ms. D'Oyley-Gay
Investor at Militia Hill Ventures
William J. Martin
Executive-in-Residence at Militia Hill Ventures